Table 8 Comparison of two groups of alfacalcidol interventions
From: Routine laboratory testing in hemodialysis: how frequently is it needed?
|  | With no interventions per year for Alfacalcidol n = 121 | With ≥ 1 interventions per year for Alfacalcidol n = 89 | P-value |
|---|---|---|---|
Age, median (IQR) | 74 (64.5, 81) | 67 (60.5, 75) | < 0.001* |
Sex, M/F (%) | 80/41 (66.1/33.9) | 51/38 (57.3/42.7) | 0.193** |
Dialysis vintage, median (IQR) | 34 (20, 66) | 35 (21, 62) | 0.880* |
Diabetes, n(%) | 61 (50.4) | 38 (42.7) | 0.268** |
Hypertension, n(%) | 116 (95.9) | 85 (95.5) | 0.999*** |
Smoking status, n(%) | 47 (38.8) | 33 (37.1) | 0.795** |
CAD, n(%) | 46 (38) | 36 (40.9) | 0.672** |
Cancer, n(%) | 15 (12.4) | 13 (14.6) | 0.642** |
Yearly number of interventions in phosphate binders’ prescription, median (IQR) | 1 (0, 2) | 1 (0, 3) | 0.199* |
Hb over one year, median (IQR) | 11.3 (10.7, 11.8) | 11.3 (10.8, 11.6) | 0.881* |
PTH over one year, median (IQR) | 207.6 (99.8, 299.2) | 338.5 (171.0, 555.7) | < 0.001* |
Serum calcium over one year, Mean ± SD | 9.02 ± 0.49 | 8.99 ± 0.48 | 0.678**** |
Serum phosphate over one year, Mean ± SD | 4.35 ± 1.08 | 4.48 ± 1.08 | 0.362**** |
URR over one year, Mean ± SD | 0.76 ± 0.05 | 0.75 ± 0.05 | 0.070**** |